1 / 37

MANAGEMENT OF MEDICALLY COMPROMISED PATIENTS

MANAGEMENT OF MEDICALLY COMPROMISED PATIENTS. SAKINAH MOHD SALEH 1090041 MOHD AZIZUL MOHD ATAN 1090042 ABDULLAH ZAHID AZHARI 1090043 NUR AMALINA ZULKEPRE 1090044 NURMARZURA ABDUL LATIF 1090045 AHMAD ZULKHAIRI RESALI 1090046 NURUL ASMAT ABDUL RAHMAN 1090048 . GROUP 3: ONCOLOGY.

gin
Download Presentation

MANAGEMENT OF MEDICALLY COMPROMISED PATIENTS

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. MANAGEMENT OF MEDICALLY COMPROMISED PATIENTS SAKINAH MOHD SALEH 1090041 MOHD AZIZUL MOHD ATAN 1090042 ABDULLAH ZAHID AZHARI 1090043 NUR AMALINA ZULKEPRE 1090044 NURMARZURA ABDUL LATIF 1090045 AHMAD ZULKHAIRI RESALI 1090046 NURUL ASMAT ABDUL RAHMAN 1090048

  2. GROUP 3: ONCOLOGY Discuss the aetiologies, clinical presentations, problems related to dental management and general management of patients with this medical problem.

  3. Introduction • Cancer is a complex illness that requires clinical care by a physician or other health care professional. • Among 50 types of childhood cancers, the most common forms include leukemias, lymphomas, central nervous system tumours, primary sarcoma of bone and soft tissues. • Chemotherapy, radiotherapy and surgery has resulted in 70% cure rate What is cancer? • Cancer is an abnormal growth of cells. Cancer cells rapidly reproduce despite restriction of space, nutrients shared by other cells or signals sent from the body to stop reproduction. Cancer cells are often shaped differently than healthy cells, they do not function properly and they can spread to many areas of the body.

  4. AETIOLOGY ONCOLOGY

  5. The factors involved may be genetic, environmental or constitutional characteristics of the individual. • Lifestyle factors : -smoking, high-fat diet and working with toxic chemicals • Genetics: • genetic mutation, exposure to chemicals near a family's residence, a combination of these factors or simply coincidence. • genetic disorders) • Exposure: -viruses such as the Epstein-Barr virus (EBV) and human immunodeficiency virus (HIV). - environmental such as pesticides, fertilizers, and power

  6. CLINICAL PRESENTATION ONCOLOGY

  7. Clinical presentations: Incidence 150 new cases per I million US children 2nd leading cause of death

  8. Clinical presentations • Incidence of childhood cancer Recent trends in childhood cancer incidence and mortality in the United States. J Nati Cancer Inst 1999;91:1051-8

  9. Clinical presentations Cancer diagnosis in children is often delayed because the presenting symptoms tend to be nonspecific and resemble those of benign conditions.

  10. Common disease of childhood cancer LEUKEMIA NON-HODGKIN’S LYMPHOMA NEUROBLASTOMA

  11. Leukemia • Definition: ‘a heterogenous group of haematological malignancies caused by proliferation of primitive white blood cells’ • Types: -Acute lymphoblastic leukemia -Acute myeloid leukemia -Chronic myeloid leukemia

  12. i- Acute lymphoblastic leukemia • Accounts for 80-85% of childhood leukemias • Defined by the presence of 30% lymphoblasts in the bone marrow. • Therapy is tailored to the risk of relapse and includes combination inductio chemotherapy, central nervous system and maintenance chemotherapy. • Approximately 2 years for total therapy. • Generally 70% of patients are cured • Prognosis depends on age, initial white cell count, cytogenic abnormalities.

  13. ii- Acute myeloid leukemia iii- Chronic myeloid leukemia 15-20% of acute childhood leukemias. Bone marrow infiltrated with primitive myeloid cells, classified by morphological apppearance. Induction therapy may be followed by bone marrow transplantation (autogenous or allogenic) Cure rate is less than acute lymphoblastic leukemia – approximately 50% Rare in childhood, accounts for <5% of cases. 2 types: -identical to adult and is characterized by presence of Philadelphia chromosome (Ph) -juvenile forms Bone marrow biopsy reveals granulocytic proliferation without an excess of blasts. Preferred therapy: allogenic bone marrow transplant within 1 year of diagnosis

  14. Leukemia Clinical features Investigations Fatigue and weight loss Anaemia Purpura Infection and febrile episodes. Hepatosplenomegaly and lymphadenopathy Bone pain Full blood count -anaemia -neutropenia -thrombhocytopenia Leucocytosis plus circulating blasts. Bone marrow biopsy required Lumbar puncture to exclude central nervous system.

  15. Problems related to dental management • Mainly as a result of cancer therapy; radiotherapy or chemotherapy • Oral problems pain, mucositis, oral ulceration, bleeding, taste dysfunction, increase risk of infection (2°), dental caries, xerostomia, osteonecrosis, trismus, neurotoxicity. • Late complicationsalterations of shape (microdontia, macrodontia, taurodontia), number (anodontia) and root formation (root shortening and blunting of the roots, root stunting) of the teeth. • Head and neck radiotherapy abnormalities in the growth and maturation of the craniofacial skeleton structures.

  16. Dental Management of Pediatric Patients Receiving Chemotherapy, Radiation

  17. General Management- Before the cancer therapy Dental procedure • Should be completed before start cancer tx- ideally • Prioritizing procedure • when all dental needs cannot be treated before cancer therapy is initiated. • Prioritize: infections, extractions (7-10 d), periodontal care (eg,scaling, prophylaxis), and removal sources of tissue irritation . • Pulp therapy • Choose extraction – avoid infection later • Endodontic tx • At least 1 week b4 therapy (if symptomatic), extract if not possible • Ortho • Perio

  18. General Management- Before the cancer therapy • Objective • To Identify, stabilise & eliminate existing & potential source infection & irritants in oral cavity • to communicate with the oncology team -patient’s oral health status, plan, and timing of treatment. • To educate the patient and parents about the importance of optimal oral care to minimise • oral problems/discomfort before, during, and after treatment • the possible acute and long-term effects of the therapy

  19. General Management- Before the cancer therapy 1-Initial evaluation • PMH • Disease/condition(type, stage, prognosis), • treatment protocol (conditioning regimen, surgery, chemotherapy, radiation, transplant), • medications (including bisphosphonates), • allergies, surgeries, secondary medical diagnoses, hematological status [complete blood count (CBC)], coagulation status, immunosuppression status, presence of an indwelling venous access line, and contact of oncology team/primary care physician(s). • PDH • Oral/dental assessment

  20. General Management- Before the cancer therapy Initial evaluation • PMH • PDH • Fluoride exposure,habits, trauma, symptomatic teeth, previous care, preventive practices, oral hygiene, and diet assessment. • Oral/dental assessment • head, neck, and intraoral examination, • OH assessment and training, • radiographic evaluation based on history and clinical findings.

  21. General Management- Before the cancer therapy 2-Preventive strategy • Oralhygiene • Brushing- 2 to 3x/day • Floss- only allowed if aptient properly trained • Poor OH- alcohol free chlorhexidine • Diet • Advice parent- non cariogenic diet • Fluoride- • Toothpaste,gel,varnish,supplement,

  22. General Management- Before the cancer therapy 2-Preventive strategy d) Trismus prevention • who receive radiation therapy to the masticatory muscles • daily oral stretching exercises/physical therapy should start before radiation is initiated and continue throughout treatment. e) Education • importance of optimal care – minimise problem/ discomfort

  23. General Management- Before the cancer therapy 3-Dental Care (haematological consideration) • absolute neutrophil count –(antibiotic prophylaxis) • >2,000/mm3: no need for antibiotic prophylaxis • 1000 to 2000/mm3: Use clinical judgment1based on the patient’s health status and planned procedures. Some authors1,5 suggest that antibiotic coverage (dosed per AHA recommendations) • <1,000/mm3: defer elective dental care.

  24. General Management- Before the cancer therapy 3-Dental Care (haematological consideration) • platelet count-( • >75,000/mm: no additional support needed. • 40,000 to 75,000/mm3: • platelet transfusions may be considered pre- and 24 hours post-operatively. • Local-ized procedures to manage prolonged bleeding may include sutures, hemostatic agents, pressure packs, and/or gelatin foams is needed. • <40,000/mm3: defer care. • other coagulation test

  25. General Management- Before the cancer therapy 4-Dental procedure • Should be completed before start cancer tx- ideally • Prioritizing procedure • when all dental needs cannot be treated before cancer therapy is initiated. • Prioritize: infections, extractions, periodontal care (eg,scaling, prophylaxis), and removal sources of tissue irritation .

  26. General Management- Before the cancer therapy Dental procedure • Pulp therapy • No studies for safety of performing pulp therapy in primary teeth before starting chemotherapy and/or radiotherapy. • Choose extraction – avoid infection later • Endodontic tx • Symptomatic non-vital permanent teeth should receive RCT at least one week before initiation of cancer therapy • if not possible- extract

  27. General Management- Before the cancer therapy Dental procedure • Orthodontic appliances and space maintainer • Poorly fitting – abrade mucosa risk of microbial invasion to deeper tissue. • Should be removed in poor OH patient • Simple,non-irritating appliance can e used if OH good • Periodontal consideration

  28. General Management- Before the cancer therapy Dental procedure • Extraction • removed ideally two weeks (or at least seven to 10 days) before cancer therapy ) • Nonrestorable teeth, root tips, teeth with periodontalpockets greater than six millimeters, symptomatic impacted teeth, and teeth exhibiting acute infections,significant bone loss, involvement of the furcation, or mobility.

  29. A. Preventive strategies • Oral hygiene • Diet • Fluoride • Lip care • Education • need for regular follow-ups (potential dental developmental problems after radiotherapy)

  30. B. Dental care • Periodic evaluation • should be seen at least every 6 months (or in shorter intervals) • moderate or severe mucositis and/or chronic oral GVHD should be followed closely for malignant transformation • Orthodontic treatment • Light force • Oral surgery • Only minor procedure

  31. Oral surgery • Non-elective oral surgical and invasive periodontal procedures • Consultation with an oral surgeon/periodontist & physician is recommended • to decrease the risk of osteonecrosis and osteoradionecrosis • Elective invasive procedures should be avoided

  32. C. Management of oral conditions related to cancer therapies • Xerostomia • Trismus

  33. References Guideline on Dental Management of Pediatric Patients Receiving Chemotherapy, Hematopoietic Cell Transplantation, and/or Radiation Handbook of Pediatric Dentistry, A Cameron, R Widmer

  34. Thank you

More Related